New drug law to speed scientific review.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 1406977.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
By charging drug companies 'user fees' that will be spent hiring new staff, the US Food and Drug Administration will reduce the time it takes to review new pharmaceuticals from an average of two years to one.
Medical subject headings
- Drug Approval
- Drug Industry
- United States Food and Drug Administration